Anyakora, Chimezie
Oni, Yetunde
Ezedinachi, Uchenna
Adekoya, Adebola
Ali, Ibrahim
Nwachukwu, Charles
Esimone, Charles
Abiola, Victor
Nwokike, Jude
Funding for this research was provided by:
USAID
Article History
Received: 13 August 2017
Accepted: 22 January 2018
First Online: 30 January 2018
Authors’ information
: C. Anyakora is the Chief of Party in Nigeria for the USP PQM program. A. Adekoya and U. Ezedinachi are USP PQM staff in Lagos, Nigeria. Y. Oni is the acting Director General of NAFDAC. I. Ali, C. Nwachukwu, and V. Abiola are staff of NAFDAC. C. Esimone is a staff of the Faculty of Pharmacy, Nnamdi Azikiwe University. J. Nwokike is the Director of the USP PQM program.
: Not applicable
: Consent to publish data obtained from the National Agency for Food and Drug Administration and Control (NAFDAC), Nigeria.
: There is no competing interest. C. Anyakora, U. Ezedinachi, A. Adekoya, and J. Nwokike are USP employees working on the Promoting the Quality of Medicines (PQM) program. Y. Oni, I. Ali, C. Nwachukwu, and V. Abiola are NAFDAC employees.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.